{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Lake Forest",
      "state": "IL",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "74720",
      "recalling_firm": "Hospira Inc.",
      "address_1": "275 N Field Dr",
      "address_2": "N/A",
      "postal_code": "60045-2579",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "US and Puerto Rico",
      "recall_number": "D-0169-2017",
      "product_description": "5% Lidocaine HCL and 7.5% Dextrose Injection, USP, 2 mL Single-dose ampule, 5 count box, Rx Only, For Spinal Anesthesia Only, Manufactured by Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4712-01",
      "product_quantity": "287,200  2 mL ampules",
      "reason_for_recall": "Failed Stability Specifications: The recalled lots did not meet the specification for color and pH throughout shelf life.",
      "recall_initiation_date": "20160629",
      "center_classification_date": "20161206",
      "termination_date": "20191120",
      "report_date": "20161214",
      "code_info": "Lot # 34-547-DK, 34-548-DK, Exp. 10/16,   Lot # 39-372-DK, Exp. 03/17     Lot Number may be followed by numbers from 01 to 99"
    }
  ]
}